Page last updated: 2024-09-04

isovitexin and Colitis Gravis

isovitexin has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, R; Mu, J; Song, J; Wang, D; Xue, T; Yu, J	1

Other Studies

1 other study(ies) available for isovitexin and Colitis Gravis

Article	Year
Isovitexin prevents DSS-induced colitis through inhibiting inflammation and preserving intestinal barrier integrity through activating AhR. Chemico-biological interactions, 2023, Sep-01, Volume: 382 Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; NF-kappa B; Receptors, Aryl Hydrocarbon; Tumor Necrosis Factor-alpha	2023

Article

Year

Isovitexin prevents DSS-induced colitis through inhibiting inflammation and preserving intestinal barrier integrity through activating AhR.

Chemico-biological interactions, 2023, Sep-01, Volume: 382

Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; NF-kappa B; Receptors, Aryl Hydrocarbon; Tumor Necrosis Factor-alpha

2023